DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial ...
As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired ...
The U.S. stock market has performed admirably so far in 2025. Stocks, as measured by the S&P 500, have appreciated more than 10% as of Sept. 4. The Dow Jones Industrial Average and the Nasdaq have ...